Model
Edge
Alnylam Pharmaceuticals, Inc.
0001708764
Filing Type
4
Filing Date
2/2/2023
Updated
2/3/23, 10:46 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership